O'BYRNE JASON (EVP & Chief Financial Officer) sold 1.0% of their position (1.63K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $15.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0001628280-26-012395
Officer· EVP & Chief Financial Officer
Since Feb 2026
-1.63K
Net shares
Net seller
$15.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.63K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.63K
Price / share
$9.53
Trade value
$15.58K
% of position
1.0%
2/24/2026
164.25K→162.62K
Total
Net shares
−1.63K
Net value
-$15.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | S · Sale | −1.63K | $9.53 | $15.58K | 1.0% | 164.25K | 162.62K |
| Total | −1.63K | -$15.58K | ||||||
Derivative Transactions0
No derivative transactions reported